Abacus Life (NASDAQ:ABL) (NASDAQ: ABL) is a specialty insurance holding company focused on the acquisition, administration and management of legacy life insurance and annuity portfolios. Established through a special purpose acquisition vehicle sponsored by Abacus Advisors, the company leverages extensive industry experience to consolidate closed blocks of in-force policies, providing policyholders with enhanced service and stability over the long term.
The company’s core activities include reinsurance transactions, block acquisitions and ongoing policy administration. Abacus Life works closely with global reinsurers and institutional investors to secure capital-efficient funding for its acquisitions, while its dedicated operations team oversees claims processing, premium collections and customer support. By integrating proprietary data analytics and risk‐management tools, the firm aims to optimize persistency and cash flow across diverse liabilities.
Since its inception, Abacus Life has completed multiple transactions in the United States, targeting portfolios that no longer align with the strategic focus of their original issuers. Headquartered in New York with additional offices in Bermuda, the company serves a broad base of policyholders, drawing on local expertise and regulatory compliance capabilities to manage assets and liabilities under various legal frameworks.
Abacus Life is led by a seasoned management team, including CEO Jonathan Burnstead, who brings over two decades of insurance and capital markets experience, and CFO Christine McBride, a veteran of actuarial-driven portfolio management. The board comprises industry veterans with backgrounds at leading insurers and reinsurers, underscoring the company’s commitment to disciplined underwriting and strategic growth.
